ACHFF (Arch Biopartners) Other Current Liabilities: $-0.00 Mil (As of Mar. 2026)


ACHFF Arch Biopartners Inc ACHFF
22 GF Score
Price $0.61
! 4 Warning Signs
View Full Analysis

What is Arch Biopartners Other Current Liabilities?

Arch Biopartners ACHFF +10.05% 22 Other Current Liabilities is $-0.00 Mil as of Mar. 2026. GuruFocus rates ACHFF with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Arch Biopartners's other current liabilities for the quarter that ended in Mar. 2026 was $-0.00 Mil.

Arch Biopartners's quarterly other current liabilities increased from Sep. 2025 ($-0.00 Mil) to Dec. 2025 ($0.00 Mil) but then declined from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($-0.00 Mil).

Arch Biopartners's annual other current liabilities stayed the same from Sep. 2023 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) but then declined from Sep. 2024 ($0.00 Mil) to Sep. 2025 ($-0.00 Mil).

Arch Biopartners Other Current Liabilities Related Terms

Arch Biopartners Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners Other Current Liabilities Chart

Arch Biopartners Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00

Arch Biopartners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 0.00 -0.00
ACHFF
22GF Score
Arch Biopartners Inc ACHFF
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Biopartners Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $-0.00 Mil mean?
Arch Biopartners (ACHFF) has a Other Current Liabilities of $-0.00 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Arch Biopartners.
Is Arch Biopartners' Other Current Liabilities too high?
Arch Biopartners' current Other Current Liabilities is $-0.00 Mil. Overall, Arch Biopartners has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Arch Biopartners' Other Current Liabilities compare to VRTX and REGN?
Arch Biopartners' Other Current Liabilities of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Arch Biopartners. Arch Biopartners's current Other Current Liabilities is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Biopartners stock overvalued right now?
Arch Biopartners (ACHFF) has a current Other Current Liabilities of $-0.00 Mil. The current Other Current Liabilities is $-0.00 Mil. Arch Biopartners' overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Arch Biopartners (ACHFF), the current Other Current Liabilities is $-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Other Exchanges 8HA:GermanyARCH:Canada
Address 545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
22GF Score

Get the complete analysis for ACHFF

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.61
Price